M

Question

Will the FDA or EMA withdraw approval of semaglutide for the treatment of obesity or diabetes in 2024?

Total Forecasters428
Community Prediction1%

Make a Prediction

50%
community: 1%
median 1.0%mean 1.3%
0%10%20%30%40%50%60%70%80%90%100%
Authors:
Opened:
Closes:
Scheduled resolution:

Comments

? comments